Flavor manufacturer Symrise has partnered with Shan Foods to intends to deliver taste solutions for food in Pakistan.
The collaboration will enable the companies to co-develop consumer-led concepts and taste solutions for high-growth categories such as culinary and snacks.
It will also advance taste, nutrition, and health food technology platforms in Pakistan.
According to Sammer Sultan, co-chairperson of Shan Foods, their partnership with Symrise reinforces their position as a brand that continuously explores new ideas and drives food innovation and taste development in Pakistan.
The companies will focus on developing, launching, and commercializing food products such as seasonings, bouillons, processed meat, snacks, and instant noodles.
Symrise’s president of food and beverage for Europe, Africa & Middle East, Walter Ribeiro, said the partnerships will help them further consolidate their foothold in the Middle East and Africa.


Singapore's Non-Oil Domestic Exports Surge 15.3% in March 2026 on AI Demand
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Heritage, desire and diplomacy: why China still values scotch whisky
Why have so few atrocities ever been recognised as genocide?
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Uranium Bull Market Gains Momentum Amid Supply Deficits and Geopolitical Tensions
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Australia's Job Market Holds Firm in March 2026 with Strong Full-Time Hiring
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
Disaster or digital spectacle? The dangers of using floods to create social media content
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Why a ‘rip-off’ degree might be worth the money after all – research study
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 



